BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 20403115)

  • 1. Capillary-lymphatic malformation, kaposiform hemangioendothelioma and delayed Kasabach-Merritt phenomenon.
    del Pozo J; López-Gutiérrez JC; Gómez-Tellado M; Nistal M; Soler R; Sacristán F; Tovar JA
    Pediatr Dermatol; 2011; 28(4):439-43. PubMed ID: 20403115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.
    Garcia-Monaco R; Giachetti A; Peralta O; Napoli N; Lobos P; Gioseffi L; Mariani G
    J Vasc Interv Radiol; 2012 Mar; 23(3):417-22. PubMed ID: 22365299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
    Jahnel J; Lackner H; Reiterer F; Urlesberger B; Urban C
    Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861
    [No Abstract]   [Full Text] [Related]  

  • 4. Intra-abdominal Kaposiform hemangioendothelioma and the benefits of laparoscopic surveillance.
    Thompson CV; Wells JM; Bowen C; Brundler MA; Kearns P; Arul GS
    Pediatr Blood Cancer; 2012 Jun; 58(6):992-3. PubMed ID: 22431247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal kaposiform hemangioendothelioma of the spleen associated with Kasabach-Merritt phenomenon.
    Shabtaie SA; Wang B; Owyong M; Ruiz-Mesa C; Corrales-Medina FF; Rojas CP; Infante JC; Neville HL; Perez EA; Sola JE; Hogan AR
    J Pediatr Surg; 2016 Jun; 51(6):1047-50. PubMed ID: 27342010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.
    Wallenstein MB; Hole MK; McCarthy C; Fijalkowski N; Jeng M; Wong WB
    Pediatr Hematol Oncol; 2014 Sep; 31(6):563-7. PubMed ID: 24047193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.
    Hermans DJ; van Beynum IM; van der Vijver RJ; Kool LJ; de Blaauw I; van der Vleuten CJ
    J Pediatr Hematol Oncol; 2011 May; 33(4):e171-3. PubMed ID: 21516018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumors.
    Fernandez-Pineda I; Lopez-Gutierrez JC; Ramirez G; Marquez C
    Pediatr Hematol Oncol; 2010 Nov; 27(8):641-5. PubMed ID: 20863161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposiform hemangioendothelioma arising in the deltoid muscle without the Kasabach-Merritt phenomenon.
    Tamai N; Hashii Y; Osuga K; Chihara T; Morii E; Aozasa K; Yoshikawa H
    Skeletal Radiol; 2010 Oct; 39(10):1043-6. PubMed ID: 20309545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J; Smink GM; Helm K; Xavier F
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant vascular malformation with thrombocytopenia in a newborn.
    Downing A; Chauhan A; Lotterman C; Craver R; Warrier R
    Clin Pediatr (Phila); 2013 Nov; 52(11):1079-82. PubMed ID: 24002050
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
    Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
    Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposiform hemangioendothelioma (with Kasabach Merritt syndrome) of the head and neck: case report and review of the literature.
    Mukerji SS; Osborn AJ; Roberts J; Valdez TA
    Int J Pediatr Otorhinolaryngol; 2009 Oct; 73(10):1474-6. PubMed ID: 19643504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly involuting congenital hemangioma associated with profound, transient thrombocytopenia.
    Rangwala S; Wysong A; Tollefson MM; Khuu P; Benjamin LT; Bruckner AL
    Pediatr Dermatol; 2014; 31(3):402-4. PubMed ID: 22937785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposiform haemangioendothelioma in a nine-year-old boy with Kasabach-Merritt phenomenon.
    Zhang G; Gao Y; Liu X
    Br J Haematol; 2017 Oct; 179(1):9. PubMed ID: 28714059
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.
    Chan S; Cassarino DS
    JAMA Dermatol; 2013 Nov; 149(11):1337-8. PubMed ID: 24005816
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
    Ji Y; Chen S; Yang K; Xia C; Peng S
    J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposiform hemangioendothelioma of the breast in an adult female.
    Kim MG; Choi YS; Park SJ; Chong SM
    Clin Breast Cancer; 2011 Apr; 11(2):135-7. PubMed ID: 21570000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenon.
    Tribolet S; Hoyoux C; Boon LM; Cheruy C; Demarche M; Jamblin P; Roberti A; Willemaers V; Viellevoye R; Rigo V; Broux I
    Arch Pediatr; 2019 Sep; 26(6):365-369. PubMed ID: 31353149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kasabach-Merritt syndrome-associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D.
    Hu B; Lachman R; Phillips J; Peng SK; Sieger L
    J Pediatr Hematol Oncol; 1998; 20(6):567-9. PubMed ID: 9856681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.